(NASDAQ:CRNX), SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) (“Crinetics”), a pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, announced today the pricing of an underwritten public offering of 7,620,000 shares of its common stock at a price to the […]

Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire January 07, 2026 SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) (“Crinetics”), a pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, announced today the pricing of an underwritten public

Best RFID Blocking Card: Consumer Verification Analysis Examines Wallet Defender Signal-Blocking Technology as January Search Volume Reaches Post-Holiday Peak Publication addresses verification gap for consumers conducting post-advertisement due diligence on RFID protection products; analysis examines Wallet Defender passive electromagnetic interference technology, business legitimacy framework, and Self-Assessment criteria as contactless card security searches increase across major

(NYSE:KLAR), SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Klarna Group plc (NYSE: KLAR) securities pursuant and/or traceable to Klarna's offering documents issued in connection with Klarna's September 10, 2025 initial public offering (the “IPO”), have until February 20,

KLAR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Klarna Group plc Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire January 07, 2026 SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Klarna Group

HOUSTON, TX, Jan. 06, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not medical advice. Medical decisions about prescription weight-management treatments are appropriately made with a qualified clinician who can evaluate individual risks and eligibility. If you purchase through links in this article, a commission may be earned at

Best Peptides for Weight Loss 2026: Oral Wegovy Launch Expands GLP-1 Format Options as Telehealth Platforms Compare FDA-Approved vs Compounded Semaglutide Access Following Oral Wegovy Introduction, Consumer Analysis Examines Injectable vs Oral Semaglutide Pricing, Compounded Tirzepatide Access Through Direct Meds, and Three-Entity Telehealth Platform Structure GlobeNewswire January 07, 2026 HOUSTON, TX, Jan. 06, 2026 (GLOBE

NEWARK, NEW JERSEY, Jan. 06, 2026 (GLOBE NEWSWIRE) — 2026 has only started, and Crown Coins Casino is already one of the most talked-about new online casinos. The casino has earned itself envied recognition after being rated the leading new online casino for 2026. This is due to the platform setting new benchmarks for what

New Online Casinos 2026: Crown Coins Rated Leading New Casino Industry Influential Platforms Highlight Crown Coins Casino for Its Sweepstakes Model, Game Variety, and Player-First Platform Design in Early 2026 GlobeNewswire January 07, 2026 NEWARK, NEW JERSEY, Jan. 06, 2026 (GLOBE NEWSWIRE) — 2026 has only started, and Crown Coins Casino is already one of

Nitric Boost Ultra Formulation Analysis: Male Wellness Industry Enters 2026 With Growing Interest in Nitric Oxide Support Supplements Industry Analysis Examines Eight-Ingredient Powdered Formula, Nitric Oxide Pathway Research, and Age-Specific Circulatory Considerations for Men Entering 2026 GlobeNewswire January 07, 2026 LOS ANGELES, CA, Jan. 06, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational